Invasive group A streptococcal infections in the San Francisco Bay area, 1989-99

Epidemiology and Infection

Volumn 129, Issue 3, 2002, Pages 471-478

  Passaro, D J ^a   Smith, D S ^a,e   Hett, E C ^a,f   Reingold, A L ^b   Daily, P ^a   Van Beneden, C A ^c   Vugia, D J ^d  

^a CALIFORNIA EMERGING INFECTIONS PROGRAM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^e KAISER PERMANENTE MEDICAL CENTER   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; ETHNIC DIFFERENCE; FATALITY; FEMALE; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MALE; NEWBORN; REVIEW; SEX RATIO; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; UNITED STATES;

EID: 0036973333     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0950268802007823     Document Type: Review

References (24)

1. McGowan JE, Barnes MW, Finland M. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases. J Infect Dis 1975; 132: 16-35.
2. Finland M, Barnes MW. Changing etiology of bacterial endocarditis in the antibiotic era. Ann Intern Med 1970; 72: 341-8.
3. Metropolitan Life Insurance Company. Metropolitan Life Insurance Company Statistical Bulletin. 1943; 24: 9.
4. Fleming D, Hirschboeck F, Cosgriff J. Minnesota Rheumatic Fever Survey, 1955. Minnesota Med 1956; 39: 208-13.
5. Gordis L. Changing risk of rheumatic fever. In: Shulman S, ed. Management of streptococcal pharyngitis in an era of declining rheumatic fever. New York: Praeger Publishers, 1984; 13-22.
6. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. New Eng J Med 1989; 321: 1-7.
7. Quiros JC, Moreno S, Cercenado E, et al. Group A streptococcal bacteremia - A 10-year prospective study. Medicine 1997; 76: 238-48.
8. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infectious, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166: 374-82.
9. Cleary PP, Kaplan EL, Handley JP, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339: 518-21.
10. Andersen MM, Ronne T. Group A streptococcal bacteraemias in Denmark 1987-89. J Infect 1995; 31: 33-7.
11. Begovac J, Kuzmanovic N, Bejuk D. Comparison of clinical characteristics of group A streptococcal bacteremia in children and adults. Clin Infect Dis 1996; 23: 97-100.
12. Cherchi GB, Kaplan EL, Schlievert PM, Bitti A, Orefici G. First reported case of Streptococcus pyogenes infection with toxic shock-like syndrome in Italy. Eur J Clin Microbiol Infect Dis 1992; 11: 836-8.
13. Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway - 1987-1988. Scand J Infect Dis 1990; 22: 421-9.
14. Wheeler MC, Roe MH, Kaplan EL, Schlievert PM, Todd JK. Outbreak of group A streptococcus septicemia in children: clinical, epidemiologic, and microbiological correlates. JAMA 1991; 266: 533-7.
15. Gaworzewska E, Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect 1988; 100: 257-69.
16. Thomas JC, Carr SJ, Fujioka K, Waterman SH. Community-acquired group A streptococcal deaths in Los Angeles County. J Infect Dis 1989; 160: 1086-7.
17. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34: 953-8.
18. http://www.census.gov/population/estimates/county/casrh/casrh06.txt
19. Kleinbaum DG, Kupper LL, Morganstern H. Epidemiological research. New York: Van Nordstrand Reinhold, 1982: 160-4.
20. Rogerson PA. A generalization of Hewitt's test for seasonality. Int J Epidemiol 1996; 25: 644-8.
21. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome, a retrospective population-based study. JAMA 1993; 269: 384-89.
22. Dan M, Maximova S, Siegman-Igra Y, Gutman R, Rotmensch HH. Varied presentations of sporadic group A streptococcal bacteremia: clinical experience and attempt at classification. Rev Infect Dis 1990; 12: 537-42.
23. Bibler PH, Rouan GW. Cryptogenic group A streptococcal bacteremia: experience at an urban general hospital and review of the literature. Rev Infect Dis 1986; 8: 941-51.
24. Norrby-Teglund A, Stevens DL. Novel therapies in streptococcal toxic shock syndrome: attenuation of virulence factor expression and modulation of the host response. Curr Opin Infect Dis 1998; 11: 285-91.